Six startups selected for GE Healthcare's India Edison Accelerator Programme
GE Healthcare's India Edison Accelerator program (third edition), focussed on technology, business strategy, and regulatory and clinical validation, has shortlisted six startups working in areas such as cardiology, oncology and genomics. The selected startups can access the Edison platform, its sales teams and customers globally for a firm footing and are eligible for USD 10-K equity-free cash grants. The selected startups are: 4BaseCare: The Bangalore-based firm offers personalised oncology care. It offers tech-assisted genome panel analyses to detect mutations in a given sample and thus obtain information about cancer. AIRA Matrix: The Thane-based company was set up by Dilip Shanghvi (of Sun Pharma) in 2011 and worked on optimising safety assessments during preclinical drug development studies. In brief, it stepped in before a drug went for clinical trial and analysed its toxicity. In 2020, it started developing solutions to aid cancer diagnosis and ensure better treatment for ophthalmological disorders. Haystack Analytics: Started in August 2019, this Mumbai-based bioinformatics startup works on genome sequencing technology. At present, it has specialised tests for tuberculosis, antimicrobial resistance, gut microbiome and a single test to identify more than 200 pathogens, including bacteria, viruses and fungi. Qritive: Set up in 2019, the startup aims to bring analytics tools and technologies to the field of pathology and digitalise the segment to make cancer diagnosis faster, more accurate and affordable. Qritive started its operations in India but shifted to Singapore in 2020. Tricog: Founded in 2014, this Bengaluru-based company offers an AI-powered and cloud-based virtual diagnostic service called InstaECG. zMed: Chennai-based firm offers ICU management processes. Initially, the company manufactured IoT hardware for ICU automation. zMed now focuses on software development for clinical automation and tele-ICU.
Want to receive such news items in your inbox? Click Here to sign up for a trial.